Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis B
NCT02287857 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 360
Last updated 2019-03-19
Summary
The purpose of this study is to evaluate the safety and efficacy of Domestic Tenofovir Disoproxil Fumarate Tablets in Chinese patients with hepatitis B ,compared with Tenofovir Disoproxil Fumarate Tablets of Gilead.
Conditions
Interventions
- DRUG
-
Domestic Tenofovir Disoproxil Fumarate Tablets
1 Domestic Tenofovir Disoproxil Fumarate Tablets and 1 blank Tenofovir Disoproxil Fumarate Tablets of Gilead
- DRUG
-
Tenofovir Disoproxil Fumarate Tablets of Gilead
1 blank Domestic Tenofovir Disoproxil Fumarate Tablets and 1Tenofovir Disoproxil Fumarate Tablets of Gilead
Sponsors & Collaborators
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
lead INDUSTRY
Principal Investigators
-
Yan yan Yu, doctor · Peking University First Hospital
-
Hao Wang, doctor · Peking University People's Hospital
-
Jun Chen, doctor · Beijing Ditan Hospital
-
Xin yue Chen, doctor · Beijing You An Hospital, Capital Medical University
-
Wen hong Zhang, doctor · Huashan Hospital
-
Qing Xie, doctor · Ruijin Hospital
-
Shan ming Wu, doctor · Shanghai Public Health Clinical Center
-
Hong Tang, doctor · West China Hospital
-
Qing Mao, doctor · First Affiliated Hospital, Third Military Medical University
-
Zhi liang Gao, doctor · Third Affiliated Hospital of Sun Yat-sen
-
Ji fang Shen, doctor · Zhejiang University
-
Jun Li, doctor · The First Affiliated Hospital with Nanjing Medical University
-
Wei Zhao, doctor · The Second Hospital of Nanjing Medical University
-
Jia Shang, doctor · Henan Provincial People's Hospital
-
Zu jiang Yu, doctor · The First Affiliated Hospital of Zhengzhou University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2019-10-31
- Completion
- 2019-10-31
Countries
- China
Study Locations
More Related Trials
-
Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study
NCT02195518 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection
NCT00736190 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Efficacy and Safety of HS-10234 in Patients With Chronic Hepatitis B Virus Infection
NCT03903796 ·Status: COMPLETED ·Phase: PHASE3
-
Tenofovir in Asian Chronic Hepatitis B Patients
NCT01728935 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
NCT02883647 ·Status: RECRUITING
-
Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients
NCT00441974 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of TAF in Reducing Clinical Events in CHB Patients Beyond Treatment Indications by Current Guidelines
NCT03753074 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Tenofovir in Naive Patients With Chronic Hepatitis b
NCT04157699 ·Status: UNKNOWN ·Phase: PHASE2
-
Tenofovir in Chronic Hepatitis B With Mild ALT Elevation
NCT01522625 ·Status: COMPLETED ·Phase: PHASE4
-
Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B
NCT00324961 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)
NCT00507507 ·Status: COMPLETED ·Phase: PHASE2
-
Three Types of Nucleotide/Nucleoside Analogues Therapy in Patients With Chronic Hepatitis b
NCT04195074 ·Status: UNKNOWN ·Phase: NA
-
A Study of Switching From Entecavir to Tenofovir Disoproxil Fumarate in Subjects With Chronic Hepatitis B
NCT03258710 ·Status: COMPLETED ·Phase: PHASE4
-
Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients
NCT03733652 ·Status: UNKNOWN ·Phase: NA
-
Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients
NCT01267162 ·Status: COMPLETED
-
Treatment Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in naïve Chronic Hepatitis B
NCT02533544 ·Status: COMPLETED
-
Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients
NCT02967939 ·Status: COMPLETED ·Phase: PHASE3
-
Antiviral Therapy for Patients With Chronic Hepatitis B Infection
NCT05382351 ·Status: UNKNOWN ·Phase: PHASE2
-
The Efficacy and Safety of Tenofovir Amibufenamide to Treat Low-level Viraemia After Entecavir Treatment
NCT05755776 ·Status: UNKNOWN
-
A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B
NCT00116805 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAF in Pregnant Women With Chronic Hepatitis B Infection
NCT04507607 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
The Effectiveness and Safety of Tenofovir Alafenamide in the Treatment of Chronic Hepatitis B Patients With Mildly Elevated Alanine Aminotransferase and Significant Liver Injury.
NCT04674423 ·Status: RECRUITING ·Phase: PHASE4
-
Tenofovir Combination or Mono-therapy for MDR CHB
NCT03597633 ·Status: UNKNOWN
-
Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B
NCT01926288 ·Status: COMPLETED ·Phase: PHASE4
-
An Study to Evaluate Safety and Efficacy of QL-007 Tablets in Combination With Entecavir or Tenofovir in Patients With Chronic Hepatitis b Who Have Received Nucleoside (Acid) Therapy
NCT04157257 ·Status: UNKNOWN ·Phase: PHASE2